Sponsor: Rubicon Genomics
Recording Date: 2/19/2014
Recording Time: 1 hour
The Boztug lab at CeMM in Vienna is searching for a Next Generation Sequencing Bioinformatician to optimize data processing of high-throughput genomic data arising from various sequencing applications including exome, genome and transcriptome sequencing data, with the overall goal to fuel research on hitherto unknown monogenic human diseases.
We are looking for a highly motivated bioinformatician with a strong interest in contributing to the genomics revolution of biomedicine and with an interest in research on rare and undiagnosed Mendelian diseases. The candidate would be part of the Boztug research group but closely interact with technologists and bioinformaticians from the BSF. He/she is expected to be able to set up and maintain data processing pipelines for a variety of next-generation sequencing applications, with a focus on DNA sequencing, in particular, identification of single-nucleotide variants and small chromosomal mutations leading to the aberrant gene function. Wet-lab experience would be a plus but not a prerequisite. In addition, the role of the candidate will be to develop novel custom-designed algorithms for analysis of phenotype-based patient cohorts to identify underlying mutations and pathways. Excellent communication skills will enable intensive exchange with both wet lab scientists and other bioinformaticians at CeMM. Given that CeMM works in highly competitive areas at the forefront of biomedical research, intellectual curiosity, flexibility and dedication to science will be key success factors.
Please submit: cover letter, curriculum vitae, academic transcripts and contact details of at least two referees to email@example.com. Please refer to Boztug lab Bioinformatician in the subject line.
Application deadline: 20 January 2014
The CeMM Research Center for Molecular Medicine is an international and interdisciplinary research institute of the Austrian Academy of Sciences. Driven by medical needs, CeMM integrates basic research and clinical expertise to pursue innovative diagnostic and therapeutic approaches focused on cancer, inflammation and immune disorders. CeMM is located in a new tailor-made building at the center of the Vienna Medical University campus, within walking distance of Vienna’s historical city center. According to a study by “The Scientist”, CeMM is among the top-5 best places to work in academia world-wide (http://the-scientist.com/2012/08/01/best-places-to-work-academia-2012). Vienna is frequently ranked the world’s best city to live. It is a United Nations city with a large English-speaking community. The official and dominating language at CeMM is English, as more than 30 different nationalities are represented.
For more information please visit the CeMM website: www.cemm.at